Heart Test Laboratories, Inc. logo

Heart Test Laboratories, Inc. (HSCSW)

Market Closed
11 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
0. 07
-0
-1.2748%
Pre Market
$
0. 07
+0 +0.5739%
132.91K Market Cap
- P/E Ratio
- Div Yield
1 Volume
-0.2 Eps
$ 0.07
Previous Close
Investors:
Add Transaction
Day Range
0.07 0.07
Year Range
0.05 0.07
Want to track HSCSW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HSCSW closed today lower at $0.07, a decrease of -1.2748% from yesterday's close, completing a monthly decrease of -1.2748% or $0. Over the past 12 months, HSCSW stock gained 39.1218%.
HSCSW is not paying dividends to its shareholders.
The last earnings report, released on Mar 12, 2026, exceeded the consensus estimates by 0.88%. On average, the company has surpassed earnings expectations by 0.88%, based on the last three reports.
Heart Test Laboratories, Inc. has completed 1 stock splits, with the recent split occurring on May 17, 2024.
The company's stock is traded on one exchange.

HSCSW Chart

People also search for

Estrella Immunopharma Inc.
$ 1.08
+1.8868%
Kalaris Therapeutics, Inc.
$ 4.72
+1.5054%
PolyPid Ltd.
$ 4.57
+1.3304%
Lantern Pharma Inc.
$ 4.07
+4.8969%
Eloxx Pharmaceuticals, Inc.
$ 12.64
+14.9091%

Heart Test Laboratories, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
BO
Brian Oliveira Clear Street Group Inc.
270,770 $37,637 $18,953.9 -$18,683.1 -49.64%

Heart Test Laboratories, Inc. (HSCSW) FAQ

What is the stock price today?

The current price is $0.07.

On which exchange is it traded?

Heart Test Laboratories, Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is HSCSW.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 132.91K.

Has Heart Test Laboratories, Inc. ever had a stock split?

Heart Test Laboratories, Inc. had 1 splits and the recent split was on May 17, 2024.

Heart Test Laboratories, Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Andrew Simpson CEO
NASDAQ (CM) Exchange
42254E112 CUSIP
US Country
15 Employees
- Last Dividend
17 May 2024 Last Split
15 Jun 2022 IPO Date

Overview

Heart Test Laboratories, Inc. is a pioneering medical technology company focused on the innovation of cardiovascular diagnostic devices. Since its incorporation in 2007, the company has dedicated itself to improving cardiac care through advanced technology. Based in Southlake, Texas, Heart Test Laboratories, Inc. primarily caters to a broad array of healthcare facilities including clinics, doctor's offices, urgent care centers, and hospitals. Utilizing cutting-edge technology, the company aims to enhance the diagnostic process for cardiac dysfunction, making it faster, more accurate, and accessible to a wider patient demographic.

Products and Services

  • MyoVista wavECG
  • The flagship product of Heart Test Laboratories, Inc., MyoVista wavECG, revolutionizes cardiac diagnostics by offering a resting 12-lead electrocardiograph (ECG) system. This innovative device not only provides the conventional ECG information necessary for detecting a range of cardiac conditions but also integrates advanced diagnostics to identify cardiac dysfunction at its early stages. This dual-capability ensures comprehensive cardiac analysis in a single, non-invasive test, making it an indispensable tool in various healthcare settings from clinics to hospitals.

Contact Information

Address: 550 Reserve Street
Phone: 682 237 7781